Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Nitto Avecia logo — Comprehensive oligo solutions, from concept to commercial.

Nitto Avecia

Comprehensive oligo solutions, from concept to commercial.

Founded 1995 United States Milford, United States 601 employees Biotechnology, Manufacturing +1

General Information

Company Name Nitto Avecia
Founded Year 1995
Location United States Milford, United States +2
Employees 601
Industries Biotechnology, Manufacturing, Pharmaceutical
Social

Get notified when Nitto Avecia moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Nitto Avecia

Nitto Avecia is a leading player in the oligonucleotide market, offering comprehensive solutions for the development and production of these therapeutics. With over 25 years of experience, the company has positioned itself as a preferred partner for pharmaceutical innovators aiming to revolutionize treatment across various diseases. Partnering with Nitto Avecia Pharma Services, the company is the first CMO to provide an end-to-end oligonucleotide solution, demonstrating expertise in handling the entire process from drug substance through drug product manufacturing. This inclusive approach allows for flexibility, reliability, and consistent quality. Founded in 1995, Nitto Avecia operates in the industries of Biotechnology, Manufacturing, and Pharmaceuticals, with its headquarters in the United States. Currently, there is no publicly available information on the last investment or the investors involved. The company's dedication to providing a comprehensive oligo solution is testament to its potential for growth and impact in the biotech and pharma sectors.

Taxonomy: oligonucleotides, therapeutics, pharmaceutical, CMO, drug development, clinical trials, biotechnology-based medicines, process validation, analytical services, stability services, drug substance, drug product, clinical development

No funding data available for Nitto Avecia yet.

Get notified when Nitto Avecia raises funding

Nitto Avecia Alternatives & Competitors

Nitto Avecia vs
Dynacure
Dynacure France

Dynacure develops new treatments for orphan disorders, focusing on CNM through Dyn101 program with I...

Series C
Biotechnology, Health Care
Nitto Avecia vs
CPC Scientific Inc.
CPC Scientific Inc. United States

Tide Partners. Concept to Commercial.

33 employees
Analytics, Biotechnology
Nitto Avecia vs
Arrivo BioVentures LLC
Arrivo BioVentures LLC United States

The Strength of a Trusted Partnership

Series B
12 employees
Biopharma, Biotechnology

FAQ About Nitto Avecia

Comprehensive oligo solutions, from concept to commercial.
Nitto Avecia was founded in 1995.
Nitto Avecia is headquartered in Milford, United States.
Nitto Avecia operates in the following industries: Biotechnology, Manufacturing, Pharmaceutical.
Nitto Avecia has approximately 601 employees.
Top alternatives and competitors to Nitto Avecia include Dynacure, CPC Scientific Inc., Arrivo BioVentures LLC, Cytoscient, hVIVO. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nitto Avecia and Dynacure are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Nitto Avecia and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy